Orgenesis and Johns Hopkins Partner to Boost Cell and Gene Therapy Manufacturing for Point of Care Treatment in Baltimore · BioBuzz
A new cell and gene therapy point of care treatment facility at Johns Hopkins University, expected to open in 2023, has boosted Baltimore’s importance as a lynchpin in the industry.
Source: biobuzz.io